Venus Remedies Share Price

Venus Remedies

CMP as on 01-Jul-22 16:00

₹ 203.10
6.15 3.12%

Open

₹ 199.00

Turnover (lac)

₹ 51

Prev. Close

₹ 196.95

Day's Vol (shares)

₹ 25,105

Day's Range (₹)

₹ 195.10
₹ 205.00

CMP as on01-Jul-22 16:01

₹ 203.75
7.5 3.82%

Open

₹ 196.00

Turnover (lac)

₹ 16

Prev. Close

₹ 196.25

Day's Vol (shares)

₹ 7,982

Day's Range

₹ 195.05
₹ 205.80

Incorporated in 1989 as Venus Glucose Pvt Ltd the company was converted into public limited company in 1994 and then changed into Venus Remedies Limited. The company was promoted and managed by Chaudhary & Family. The company was mainly engaged in I/V fluids & injectables,ceftazidime,amlodipine,gliclazide,lisinopril.The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana. In 1994 it introduced Eye/Ear/Nose drops. The company received the certificate as WHO-GMP as specified by WHO,Geneva. Venus Remedies set up a Cephalosporin project with an Australian collaboration with US-FDA standards at a cost of Rs.4.5 crores. The company is manufacturing injections for the top companies like Panacea Biotech ltd,Morepan Labortories ltd etc.In 2001 with the help of Product Development Committee(PDC) Venus Remedies had introduced 13 new products in the Animal Health Division namely Megox-3000,Paroxin-3000,Pisa-3000,Mical,Ronid,Dexolyte and Detox.

  • Chairman & Managing Director

    Pawan Chaudhary
  • Joint Managing Director

    Manu Chaudhary
  • Deputy Managing Director

    Peeyush Jain
  • Executive Director

    Ashutosh Jain
  • Independent Director

    Gilbert Wenzel
  • Independent Director

    S. K. Chadha
  • Company Secretary

    Neha Kodan
  • Independent Director

    Pravindra Singh Chauhan
  • Independent Director

    Navdeep Sud
  • Addtnl Independent Director

    Savita Gupta

Registered Office

S C No 857 Cabin No 10 2nd Flr,
N A C Manimajra,Chandigarh,
Chandigarh-160101

REGISTRAR OFFICE

Narang Tower,
Naraina Ind Area,New Delhi-110028
INDIA